Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- Pfizer made the case for COVID-19 vaccine booster shots after saying protection starts to wane around six months;
- The CDC changed its COVID-19 testing guidance, saying even vaccinated people should get tested after exposure;
- Biotechs want to tap into the $115 billion synthetic-cannabis market.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…

Justin Tallis – Pool / Getty Images

Pfizer doubles down on the case for COVID-19 vaccine booster shots
- Pfizer on Wednesday advocated for booster shots of its COVID-19 vaccine.
- The pharma giant said protection against mild illness started to wane after about six months.
- The vaccine's protection against severe disease has held up, even against the Delta variant.

A medical worker performs a PCR test for COVID-19 on August 31, 2020.
Alain Jocard/AFP/Getty Images

Alain Jocard/AFP/Getty Images
The CDC quietly changed its guidance to say even vaccinated people should get tested if they've been exposed to COVID-19
- Until Tuesday, the CDC maintained that fully vaccinated people did not need to get tested for COVID-19, unless they developed symptoms.
- But, new data shows vaccinated people may be able to transmit the Delta variant just as well as the unvaccinated.
- The CDC is now urging anyone who's been in close contact with someone who has COVID-19 to get tested 3-5 days later, so they don't put others at risk.

An employee holds a test-tube as he works in the tissue culture laboratory of Pharmocann, an Israeli medical cannabis company in northern Israel January 24, 2019.
Amir Cohen/Reuters

Amir Cohen/Reuters
Biotechs are betting millions on unlocking the $115 billion synthetic-cannabis market
- Biotechs are chasing the $115 billion market for synthetic cannabis compounds.
- These compounds range from the better-known THC and CBD to rare compounds such as CBG and CBN.
- Producing these compounds synthetically has some distinct advantages over traditional growing.
More stories we're reading:
- Cuomo pushes private New York employers to bring workers back into the office by Labor Day even as he warns about the Delta variant (Insider)
- Humana in its second-quarter earnings call warned of "uncertainty" for the rest of the year as COVID-19 cases spike (Healthcare Dive)
- Department of Homeland Security will require all employees to wear masks and socially distance, even if they're vaccinated (Insider)
- Female surgeons are at greater risk for pregnancy loss (The New York Times)
- Lydia
Read the original article on Business Insider